Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Oral Viagra and Sublingual Sildenafil Wafer
NCT02850718Phase 3Completed
- Sponsor
- iX Biopharma
- Start
- Mar 2016
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP-001 in erectile dysfunction (ED), sponsored by iX Biopharma. Started Mar 2016; status: completed.
02
Drugs
ASP-001
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT02850718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02850718.